Journal Policies
International Science Publications, LLC
Publication Office: 26159 Chardon Road, Richmond Heights, OH 44143
Administrative office 42 Castle Pines Dr., New Orleans, ohio, New Orleans, LA 70112
International Science Publications publishes a group of an international peer reviewed open access journals in the field of Immunology, Cell biology and Physiology, Biotechnology, Public Health including Developmental biology, Genetical biology, Toxicology, Environmental biology and Advances in Agricultural Sciences.
Dr. Anil Mishra started this journal with an aim to support the wider scientific community Our aim is to provide the academicians, researchers, and future generations a forum to publish their research findings and to open suggestions for further research. It invites full papers, short communications, reviews, and editorials on related respective journals. Our publications have rapid Peer Review process with International Readership. We publish high quality articles and have simple and effective submission process. Individual DOI number will be provided to each published manuscript.
Scientific Misconduct
International Science Publication (ISP) will evaluate the credibility of all allegations of scientific misconduct, e.g., suspected fabrication or falsification of data, double publication, or plagiarism. If the Editor-in-Chief determines that an allegation has merit, s/he will first attempt to address the matter with the Corresponding Author. Should that fail to resolve the situation satisfactorily, the Editor-in-Chief will contact the institution of the Corresponding Author to request an investigation; the Editor-in-Chief may also contact the coauthors and/or the funder(s) of the published research.
Until the matter is clarified, no additional submissions by any author of the disputed manuscript or published article will be considered for publication. If scientific misconduct is confirmed by the institution, and no request for retraction is made either by the institution or by any author, the Editor-in-Chief will report his/her findings to a representative of the ISP Publications Committee, and in consultation with a representative, will decide appropriate action.
Only the Corresponding Author, coauthors, and appropriate representative(s) of the relevant institution(s) will be apprised of the status of, or any action(s) taken in response to, allegations of scientific misconduct.
Original Data
Authors are expected to retain the original, raw data presented in a published article for the length of time required by the authors’ funding source or institution; if the institution or funding source does not have a data retention policy, then data should be kept for at least 6 years after publication. Authors must submit original data upon the request of reviewers or editors.
Embargo Policy
For manuscripts considered to be in press or approved for publication, the public release of information should not precede the actual publication of the work. The publication date is defined as the date the first copy is mailed from the printer or the first day the article is posted online. Please note that the issue date and mail dates do not necessarily coincide. This embargo policy protects the peer-review process and the newsworthiness of the scientific content of published articles, and minimizes the chance for the appearance of misinformation in the lay press. The policy also ensures that scientists have access to all relevant information at the same time as the public. These restrictions do not apply to the presentation of the work at scientific conferences or symposia that precede the actual publication date. Although news reporters may be present at such meetings or symposia, information, tables, or illustrations that in any way duplicate the content of a manuscript submitted for publication or in press should not be provided to reporters by the authors. In particular, press conferences should not be held before the embargo date. The official release of videotape presentations and electronic prepublication of articles on the Internet should adhere to the embargo policy. Violations of these policies are legitimate grounds for withdrawal of the article from publication or other measures that ISP may choose to take.
Disclosures
All funding sources must be disclosed in a footnote to the title; anonymous or pseudonymous funders are not permitted.
Any potential conflict of interest in a submitted manuscript must be disclosed in the “Conflict of Interest Statement” section of the online submission system.
All disclosures will remain confidential during the review process, but papers accepted for publication will acknowledge conflict of interest and financial interests in a published disclaimer describing the nature of the interests. If authors declare no conflict of interest or financial interests, this also will be noted in a published disclaimer.
Image Manipulation
Figures in manuscripts considered for acceptance will be screened for evidence of manipulation. Manuscript acceptance is contingent upon a satisfactory outcome of the screening process. As a result of screening, authors may be asked to supply the original (raw) data upon which the figures were based. Inability to supply the original data may result in rejection of the manuscript. If the editors deem that the manipulation has affected the interpretation of the data, the manuscript will be rejected for publication.
NIH Public Access Policy
As of April 7, 2008, the U. S. National Institutes of Health (NIH) requires that manuscripts accepted for publication and that describe research funded in whole or in part with NIH funds be deposited into the NIH PubMed Central (PMC) repository.
In addition to NIH, a number of additional funding agencies also mandate submission to PMC/Europe PMC. AAI will also deposit on behalf of authors funded by HHMI, Wellcome Trust, and MRC-UK; for details, see “Archiving in PMC/Europe PMC“.
This free service is not applicable to authors who are not funded by NIH, HHMI, Wellcome Trust or MRC-UK.